INTRODUCTION
Protein S is a vitamin K-dependent plasma protein of 75000 M, (DiScipio and Davie, 1979 ) that acts as a non-enzymic cofactor for the anti-coagulant plasma serine protease, activated protein C (APC) (Walker, 1981a (Walker, , 1984 . Protein S is also a direct anticoagulant that inhibits prothrombinase by binding directly to factors Va and Xa . The essential physiologic role of this cofactor in the regulation of thrombosis is demonstrated by reports that 12 to 18 % of young adult patients with recurrent venous thrombotic disease are heterozygous for protein S deficiency (Bertina, 1985; Comp et al., 1986; Gladson et al., 1988) , that severe deficiency of protein S can present with purpura fulminans, and that a significant percentage of patients with arterial thrombosis have low levels of free protein S (Thommen et al., 1989) . The regulation of protein S activity in human plasma is complex. Approximately 60 % of plasma protein S circulates complexed with C4b binding protein (C4BP) and 40 % of protein S is free (Dahlback and Stenflo, 1981) . Only the free form of protein S exhibits anti-coagulant cofactor activity (Comp et al., 1986; Dahlback, 1986) . Thrombin cleavage of bovine protein S at two arginine residues in the so-called thrombin-sensitive loop, i.e. residues 52 and 70, destroys its anticoagulant cofactor activity. Human protein S has three potentially susceptible arginine residues in this region (residues 49, 60, and 70) . Protein S is present in platelets and endothelial cells, and these cells, as well as platelet microparticles, provide surfaces for the expression of APC and protein S anti-coagulant activity (Schwarz et al., 1985; Fair et al., 1986; Schwalbe et al., 1990) . Human genes coding for protein S and for a protein S pseudogene have been sequenced and are designated protein Sca and protein S,B, respectively (Edenbrandt et al., 1990; Ploos van Amstel et al.,1990; Schmidel et al., 1990) . sequences show that protein S residues 420-434 are highly conserved in all four species with the notable exception of Lys-429-Ile in porcine protein S. Differences between porcine and human protein S, e.g. Lys-429-Ile, Lys-43-Ala, Ser-197-Leu, Ser-199-Phe, Glu-463-Gly, Lys-571-Glu, Asn-602-Ile, Gln-607-Pro, may contribute to the decreased affinity of porcine protein S for human C4BP. Moreover, the species specificity of cofactor activities of various species of protein S is determined for human versus bovine-activated protein C, and these results, combined with sequence comparisons, agree with previous evidence that the thrombin-sensitive region and the first epidermal growth factor domain of protein S, i.e. residues 47-116, are responsible for recognition of activated protein C.
In the current study, we report the sequences of protein S from rhesus monkey and pig and demonstrate their functional similarity to human protein S in both anti-coagulant cofactor activity and in binding to C4BP, and show that differences in affinity for human C4BP correlate with non-conservative amino acid substitutions in protein S regions implicated in C4BP binding by synthetic peptide studies .
EXPERIMENTAL Materials
All reagent chemicals were of reagent grade or better. When available, molecular biology grade reagents were used. Automated fluorescent terminator sequencing was performed and synthetic oligonucleotides were prepared by Dr. Charles Glass (The Scripps Research Institute). Human C4BP was purified as previously described (Griffin et al., 1992) . Human (Gruber et al., 1989) and bovine (Gladson et al., 1989 ) APC were prepared as described. C4BP was biotinylated by a previously published method Figure 1 ) and consisted of the expected doublet at 69 kDa (Dahlback, 1983 was incubated with the blot for 2 h at room temperature. This step was followed by three washes with blocking buffer. u25I-labelled protein S was used for detection (Lammle et al., 1986 Determination of apparent affinity constants Purified human or porcine protein S (10 ,al/ml) was immobilized on microtitre wells . The plate was blocked with TBS containing 2 0°BSA. Wells were then washed and incubated with biotinylated human C4BP (0-50 ,ug/ml) in dilution buffer for 2 h at room temperature. Bound biotin was determined as described above. Data were subjected to Scatchard analysis (Scatchard, 1949) ability of purified human C4BP to neutralize protein S cofactor activities in the different plasmas was studied. Figure 2 shows the effect of preincubation of human or rhesus monkey plasma used as a source of protein S with increasing concentrations of purified human C4BP prior to assaying protein S activity in the APC cofactor assay. The results in Figure 2 demonstrate that human C4BP potently neutralized monkey, porcine, bovine, and human protein S activity. Note that consistent with previous reports in human (Dahlback, 1986) T   MRVLGGRCGALACLLLVLPVSEANFLSKQQASQVLVRK RRAISSLE00 TK0GNLERECIEELCKEERTVFNDPS FQTGLFTA   60  70  80  90  100  110  120  130  140 S   160  170  180  190  200  210  220  230  240  250 Figure 5 Predicted human (hum), bovine, porcine, rabbit, and rhesus monkey protein S (PS) amino acid sequences Alignments of protein sequences inferred from the cDNA sequences were performed using the University of Wisconsin Genetics Computer Group software package (Devereux et al., 1984 Stenflo, 1981) and thus the intensity of the fastest migrating bandl ini Figure 3 yielded an estimate of the total protein S antigen: Since-labelled protein S was used for detection (Lammle et al., 1986) , the other bands represented affinity labelling of plasma proteins that bound to protein S, such as C4BP (Dahlback and Stenflo, 1981) and factor V . Immunoblotting of SDS gels of serial dilutions of plasma followed by autoradiography and densitometry yielded the estimate that porcine plasma contains 72 % of the total human protein S antigen concentration (results not shown). Although these results were only semi-quantitative due to the possibility of differential recognition of animal protein S by anti-human protein S antibodies, the data were consistent with the assumption that the concentrations of protein S differed by, at most, a few-fold. This suggested that the difference in the concentration of human C4BP needed to neutralize the protein S cofactor activity in these two plasmas did not result from a markedly higher amount of protein S circulating in porcine plasma, but was caused by a higher Kd of human C4BP for porcine protein S than for human protein S.
The hypothesized higher Kd of purified porcine protein S compared with human protein S for human C4BP was confirmed directly using Scatchard analysis of solid-phase binding assays employing purified proteins. In the presence of calcium, human protein S bound to human C4BP-coated wells with an apparent Kd of 0.5+0.05 nM, while partially purified porcine protein S bound to these wells with an apparent Kd of 9.2 + 1.1 nM (Figure  4) , confirming that the lesser ability of human C4BP to neutralize porcine protein S resulted from lower affinity interaction. The Sequences of rhesus monkey and porcine protein S To examine possible amino acid sequences important for the species specificity of protein S cofactor activity for APC and for the differences in affinity for human C4BP, the cDNAs for rhesus monkey and porcine protein S were cloned from liver RNAs and subjected to double-stranded DNA sequencing. The sequences have been deposited in the GenBank database under accession numbers L31380 and L31379, respectively. The rhesus monkey and porcine protein S cDNA sequences were aligned with the sequences for human protein Sa and bovine protein S ) (results not shown). Fifty-six nucleotide differences between monkey and human protein S were observed in the coding region, corresponding to 3.0 % difference. One of these, the C to T transition at nucleotide 308, was present in only 5/13 clones sequenced in that region and therefore may represent a polymorphism. The above data suggest that in rhesus monkey liver, as in human liver, there is only one expressed protein S gene. A single porcine cDNA sequence was observed that differed from human protein Sa at 223 positions in the coding region, corresponding to 10.3 % difference.
The inferred amino acid sequences for the rhesus monkey, porcine, bovine, rabbit, and human protein Sa are aligned in Figure 5 . The rhesus monkey cDNA coded for a polypeptide with a typical prepropeptide sequence and a processed protein S molecule of 635 residues that aligns perfectly with the human protein S sequence of 635 residues without insertions or deletions. The porcine sequence coded for a similar protein with a single amino acid deletion relative to human protein S in the same position as the deletion in bovine protein S (Figure 5 ). Many of the sequence differences are common to human and rhesus monkey protein S as compared with the bovine and porcine protein S. These are indicated schematically as asterisks in Figure 6 . The distribution of such common changes is non-uniform. Only one such change occurs in the ycarboxyglutamic acid-containing domain, Asp-38-Glu. There are none in the aromatic stack region. Four such dual changes are found in the short thrombin-sensitive loop, namely Arg-49-Gly, Gln-52-Arg, Thr-53-Ala, and Gln-61-Leu. The first epidermal growth factor (EGF)-like domain has six: Ser-81-Asn, Tyr-90-Phe, Ser-92-Thr, Lys-97-Gln, Thr-103-Ile, and Pro-106-Ser. There are no common changes in the second EGF-like domain and only one in the third EGF-like domain, Leu-195-Pro. The fourth EGF-like domain has two such common changes, Thr-223-Ser and Ser-245-Pro. The sex hormone binding globulin (SHBG)-like domain has 39 changes that differentiate the porcine/bovine sequences from the human/rhesus monkey sequences. These include the substitution at residue 422, which is Ile in human and monkey protein S, but Val in porcine, rabbit, and bovine. This residue lies within the peptide 420-434 that we have implicated as part of the C4BP binding site in protein S . The above groups of amino acid changes are significant in view of the species specificity displayed by protein S in its cofactor activity towards APC. A recent report (He and Dahlbaick, 1993) has indicated that bovine APC is able to utilize rabbit protein S as a cofactor under appropriate conditions. The sequence of rabbit protein S (He and Dahlbick, 1993 ) is included in Figure 5 for reference. Of the above-listed residue differences, rabbit protein S shares Arg-49-Gly, Gln-52- The inferred protein S structures are shown schematically with disulphide bonds assigned as in the human sequence. Amino acid residues shared by human and rhesus monkey which are different from residues common to both porcine and bovine protein S (see Figure 5) are indicated by asterisks. Gla, y-carboxyglutamic acid domain; TSR, thrombin-sensitive region; EGF, EGF-like domain; SHBG, SHBG-like domain.
Arg, Thr-53-Ala, Ser-81-Asn, Lys-97-Gln, Thr-103-Ile, Thr-223-Ser, and Ser-245-Pro.
DISCUSSION
In this study, functional differences between protein S molecules from different species are used to identify specific residues that may be important for these two protein S functions. Rhesus monkey and porcine protein S in plasma are able to serve as cofactors for human and bovine activated protein C respectively. The restriction of human or rhesus monkey protein S cofactor activity to human APC and the corresponding restriction of porcine and bovine protein S cofactor activity to bovine APC suggest that residues common to these pairs of protein S sequences are likely to be involved in interactions with APC. Recent evidence that rabbit protein S can act as a cofactor for bovine APC and the report of the sequence for rabbit protein S (He and Dahlback, 1993) can be used to narrow further the list of most likely candidate residues.
The relationship of protein S structure to its binding to APC and C4BP can be analysed by comparison of the sequences and functional properties of rhesus monkey and porcine protein S to those of human and bovine protein S. A peptide from the SHBG domain of protein S representing residues 420-434 provides an essential site for interaction between human protein S and human C4BP (Femdndez et al., 1993) . The current study shows that the sequence of this region is highly conserved in human, rhesus monkey, and bovine protein S (Figure 5 ), eash of which interact with human C4BP in a similar manner (Figure 2 ) as does rabbit protein S which binds to human C4BP (He and Dahlback, 1993) . Since the overall protein S sequences are so similar, the observed difference in Kd (Figure 4 ) is assumed to result from interspecies sequence differences in regions that He and Dahlback (1993) and Lundwall et al. (1986) or cloned as described. Gas6 sequences were obtained from Manfioletti et al. (1993) . Alingments were performed using PILEUP from the University of Wisconsin Genetics Computer Group package (Devereux et al., 1984 (Walker, 1989) . Inspection of the four protein S sequences in this region ( Figure 5 , Table 1 ) indicates a high degree of conservation in this area. Site-directed mutations affecting residues 608, 609, 611, and 612 do not affect the ability of human protein S to interact with C4BP (Chang et al., 1992; Nelson and Long, 1992) . At minimum, these data suggest that residues 608, 609, 611, and 612 are not essential for C4BP binding. Table 1 shows a comparison of the 420-434 and 605-614 peptides of protein S from all five species to the equivalent regions of human and mouse gas6, a growth arrest specific protein made by fibroblasts that is > 40 % identical to protein S overall (Manfioletti et al., 1993) . The region at 605-614 is extremely well conserved between protein S and gas6, while homology at 420-434 is much weaker (Table 1) . Since it is unlikely that gas6 also binds to C4BP, this provides further evidence against a functional role for these residues in C4BP binding.
Overall, the three-dimensional structures of the five protein S molecules from various species must be extremely similar, given the degree of sequence identity (> 80 %), the identical number and position ofcysteine residues, and the difference in polypeptide length of only one residue. Since human C4BP has -20-fold lower affinity for porcine than for human, bovine, or rhesus monkey protein S (Figures 2 and 4) , it is interesting to note the residues that are identical in the last three molecules but different in porcine protein S. Inspection of the sequence data in Figure 5 shows that there are 23 such residues. Nineteen of these also differ from rabbit protein S. Since previous studies (Walker, 1989; have suggested that synthetic peptides with sequences representing 32-46, 187-200, 353-368, 420-434, and 605-614 inhibit interaction of human protein S with human C4BP to varying degrees, the following amino acid differences between human and porcine protein S are particularly noted: Lys-43-Ala, It is therefore speculated that one or more of these noted differences, but especially Lys-429-Ile and perhaps Gln-607-Pro, may be responsible for much of the decreased affinity exhibited by porcine protein S for human C4BP. Other residue differences such as Gly-370-Glu could conceivably also play a role, but the observation that synthetic peptides representing other regions such as that comprising residues 359-372 fail to inhibit binding of the two proteins does not support this possibility.
Human and rhesus monkey protein S are active cofactors for human APC but not for bovine APC, while the converse is true for bovine and porcine protein S. Rabbit APC is more active with bovine than with human APC (He and Dahlback, 1993) . Inspection of the sequence data in Figure 5 for residues which are common to human and monkey protein S and whose identity is different from residues that are common to porcine and bovine protein S detects 47 such residues. The integrity of the thrombinsensitive loop, residues 47-72, is essential for protein S anticoagulant cofactor activity , and interactions between APC and protein S may involve the EGF-like domains (Stenflo, 1991) . It is unlikely that the SHBG domain is involved in protein S-APC interactions since deletion of the C terminal 30 residues (Nelson and Long, 1992) or the entire SHBG domain (Chang et al., 1993) has no effect on protein S cofactor activity. The shared amino acid changes for human/ rhesus monkey versus bovine/porcine protein S in these regions involve: Arg-49-Gly, Gln-52-Arg, and Gln-61-Leu in the thrombin-sensitive loop; Ser-81-Asn, Ser-92-Thr, Lys-97-Gln, Thr-103-Ile, and Pro-106-Ser in the first EGF-like domain; none in the second EGF-like domain; only Leu-195-Pro in the third; and Thr-223-Ser in the fourth EGF-like domain, with Ser-245-Pro nearby. Among these, the rabbit sequence has the same amino acid as the human and monkey protein S only at residue 106; at most of the others it has the same residue as the porcine and bovine protein S. The superior ability of rabbit protein S to act as a cofactor for human APC compared with bovine APC (He and Dahlback, 1993) suggests that one or more of the protein S residues, 61, 92, or 106, may play a pivotal role in its interaction with APC. Interestingly, only three such identified amino acid differences in the region of the second, third, and fourth EGF-like domains are found, Leu-195-Pro, Thr-223-Ser, and Ser-245-Pro, at which the rabbit sequence had Pro, Ser, and Pro, respectively, which suggests that these domains are not likely to be responsible for the observed species specificity of protein S for APC. Taken together, the above data suggest that Arg-49, are likely candidates for residues in human protein S that may interact with APC.
